AYLA insider filings
Old Ayala, Inc — 32 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-01-24. Screen AYLA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AYLA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Old Ayala, Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-01-24 | 4 | aMoon Growth Fund Limited Partnership — 10% owner Schindel Yair Chaim | Disposition to issuer (D): 2,991,473 | EDGAR |
| 2023-01-23 | 4 | Gordon Gary B. — Chief Medical Officer | Disposition to issuer (D): 58,520 · Disposition to issuer (D): 89,000 (derivative) · Disposition to issuer (D): 19,170 (derivative) · Disposition to issuer (D): 31,950 (derivative) | EDGAR |
| 2023-01-23 | 4 | Bisker-Leib Vered — Director | Disposition to issuer (D): 8,750 (derivative) · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 6,250 (derivative) | EDGAR |
| 2023-01-23 | 4 | Mamluk Roni — President & CEO, Director | Disposition to issuer (D): 265,345 · Disposition to issuer (D): 47,299 (derivative) · Disposition to issuer (D): 76,680 (derivative) · Disposition to issuer (D): 127,800 (derivative) | EDGAR |
| 2023-01-23 | 4 | Spiegel Robert J. — Director | Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 6,250 (derivative) | EDGAR |
| 2023-01-23 | 4 | Maimon Yossi — CFO, Secretary and Treasurer, Director | Disposition to issuer (D): 69,872 · Disposition to issuer (D): 70,500 (derivative) · Disposition to issuer (D): 9,460 (derivative) · Disposition to issuer (D): 19,170 (derivative) · Disposition to issuer (D): 31,950 (derivative) | EDGAR |
| 2023-01-23 | 4 | SIDRANSKY DAVID — Director | Disposition to issuer (D): 250 · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 12,500 (derivative) | EDGAR |
| 2023-01-23 | 4 | GOLDBERG MURRAY A — Director | Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 6,250 (derivative) · Disposition to issuer (D): 6,250 (derivative) | EDGAR |
| 2022-06-15 | 4 | Bisker-Leib Vered — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Spiegel Robert J. — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | SIDRANSKY DAVID — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | GOLDBERG MURRAY A — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2022-05-16 | 4 | Gordon Gary B. — Chief Medical Officer | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2022-05-16 | 4 | Mamluk Roni — President & CEO, Director | Grant/award (A): 120,000 @ $0 | EDGAR |
| 2022-05-16 | 4 | Maimon Yossi — CFO, Secretary & Treasurer | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2022-01-05 | 4 | Gordon Gary B. — Chief Medical Officer | Grant/award (A): 31,950 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Mamluk Roni — President & CEO, Director | Grant/award (A): 127,800 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Maimon Yossi — CFO, Secretary & Treasurer | Grant/award (A): 31,950 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Bisker-Leib Vered — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Sone Todd — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | Spiegel Robert J. — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | SIDRANSKY DAVID — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-06-14 | 4 | GOLDBERG MURRAY A — Director | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | SIDRANSKY DAVID — Director | Purchase (P): 200 @ $15.27 · Purchase (P): 25 @ $15.02 · Purchase (P): 1 @ $9.60 · Purchase (P): 4 @ $11.86 · Purchase (P): 5 @ $11.07 · Purchase (P): 10 @ $10.07 · +2 more | EDGAR |
| 2021-02-26 | 4 | Gordon Gary B. — Chief Medical Officer | Option exercise (M): 3,000 @ $5.16 · Sale (S): 3,000 @ $17.46 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Mamluk Roni — President & CEO, Director | Sale (S): 15,200 @ $19.86 · Sale (S): 7,126 @ $17.89 · Sale (S): 10,800 @ $17.40 | EDGAR |
| 2021-01-22 | 4 | Gordon Gary B. — Chief Medical Officer | Option exercise (M): 3,000 @ $5.16 · Sale (S): 3,000 @ $15.03 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Mamluk Roni — President & CEO, Director | Sale (S): 19,466 @ $15.03 · Sale (S): 1,406 @ $15.04 | EDGAR |
| 2021-01-06 | 4 | Gordon Gary B. — Chief Medical Officer | Grant/award (A): 8,520 @ $0 · Grant/award (A): 19,170 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Mamluk Roni — President & CEO, Director | Grant/award (A): 34,080 @ $0 · Grant/award (A): 76,680 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | Maimon Yossi — CFO, Secretary & Treasurer | Grant/award (A): 8,520 @ $0 · Grant/award (A): 19,170 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | Bisker-Leib Vered — Director | Grant/award (A): 8,750 (derivative) @ $0 | EDGAR |
Recent 8-K events — Old Ayala, Inc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-01-25 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-01-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-11-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-11-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-10-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-07-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-06-14 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-06-03 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AYLA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs